MOTS-c Is Not a Workout in a Vial

You step on the scale at 55, and it shows the same number it did at 48. Victory, right? Then the grocery bags feel heavier, the stairs feel steeper, and your jeans fit differently anyway.

Your scale isn't lying, exactly. It's keeping a secret. With World Menopause Day on Sunday, let's spill it. Then we'll cover what actually helps and meet MOTS-c, a buzzy peptide the internet sells as "exercise in a vial."

Why is my scale keeping secrets?

A long-running US study called SWAN followed women through menopause with body scans. As the transition began, fat gain doubled its pace while lean mass, which is mostly muscle, started to shrink.

Here's the sneaky part. On the scale, the trend line didn't change. Fat went up, muscle went down, and the total kept plodding along like nothing happened. Same weight path, different body.

Bone follows a similar script. In the same study, bone loss was fastest in a window that started about a year before the last period.

Most of a decade's spine loss happened in that stretch. None of this is a diagnosis. It's your body doing a midlife remodel without asking the homeowner.

So what actually helps?

Here's my favorite study on this. Australian researchers took about 100 women, average age 65, with low bone mass. Half did heavy lifting plus impact moves for 30 minutes, twice a week, with coaches watching every rep. The other half did a gentle home program.

After eight months, the heavy-lifting group's spine density went up. The gentle group's drifted down. Strength and everyday-movement tests improved too, and the only reported problem was one minor back spasm.

It's one trial, the women were screened first, and the supervision was intense. But it pushed back hard on the old idea that heavy weights are off-limits for fragile bones.

The everyday list, from US activity guidelines and aging experts:

Strength train all your major muscle groups on two or more days a week.

Add balance work, like standing on one leg while the kettle boils.

Build up slowly, ideally with a trainer or physical therapist. If you have a bone or joint condition, ask your clinician what's safe first.

Get enough protein at meals. Aging experts say older adults need more than younger adults to hold onto muscle.

Gentle is nice. Your bones like being mildly surprised.

Wait, my muscles make a peptide?

Kind of, and this is the fun part. Your cells run on tiny power plants called mitochondria. They carry their own little stash of DNA, separate from the main instruction manual.

In 2015, scientists at the University of Southern California described a short peptide coded in that stash. It's a chain of 16 amino acids, and they named it MOTS-c.

Think of it as a text message the power plants send to the rest of the cell: "Busy day. Adjust."

In 2021, the same lab put ten young men through a hard interval ride on stationary bikes. Afterward, MOTS-c in their thigh muscle jumped about twelvefold, and blood levels rose too. Exercise, it seems, sends the text.

What did it do in mice?

Pretty impressive things, for mice. Old male mice that started MOTS-c late in life had stronger grip and walked better than untreated mice.

In a 2016 study, researchers removed female mice's ovaries, a standard lab stand-in for menopause. MOTS-c injections slowed the bone loss that followed, at least on scans of mouse bones.

Now notice who's missing. The exercise study was ten young guys. The aging mice were all male. The only "menopause" in this story was surgical, and it happened to rodents. Nobody here is a woman over 50.

A 2026 study from Copenhagen added a twist. It suggests working muscle may not even be where the extra MOTS-c in your blood comes from. Scientists are still arguing about who sent the text.

Your workout sends the text. Bottling the text doesn't do the workout.

So has anyone tested it in people?

Not in a way you can read yet. When FDA scientists reviewed MOTS-c for a meeting this summer, they searched the published research and found no studies of giving it to people. They also noted nobody knows exactly what it docks onto in the body.

An FDA advisory panel still voted narrowly in July to recommend letting compounding pharmacies make it. That vote is advice, not an approval, and FDA hasn't acted on it. Sports anti-doping lists ban it, too.

A placebo-controlled trial in adults with prediabetes started this year. Results aren't expected before 2027, and it isn't studying muscle, bone or menopause.

Meanwhile, the internet has filled the gap. One clinic page we read quotes grip-strength results from a "MOTS-c sarcopenia trial" and gives its registry number. We looked it up. It's a study of AI that scores colonoscopy prep.

Literature, not lore.

If you remember one thing…

After menopause, the scale can stay put while muscle and bone quietly slip. Lifting has real women behind it, and balance work and enough protein have solid expert backing. MOTS-c is a fascinating clue about why exercise works, and so far, mostly mice have read it.

Everything Inspired Labs carries is Research Use Only: lab material, not a workout, not a menopause treatment, and not for your body. Nothing here is medical advice.